Sitagliptin
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of Pennsylvania
Overview
Sitagliptin is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Sitagliptin clinical trials
Explore related
Medical disclaimer. This page summarizes research about Sitagliptin for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.